Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical Inc (NY: GMED )

51.95 +1.47 (+2.91%)
Official Closing Price Updated: 7:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,061,977
Open 51.19
Bid (Size) 50.13 (1)
Ask (Size) 56.00 (1)
Prev. Close 50.48
Today's Range 50.89 - 51.96
52wk Range 43.38 - 62.88
Shares Outstanding 135,372,391
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
For those who appreciate growth without the sticker shock, GLOBUS MEDICAL INC - A (NYSE:GMED) is worth considering. 
Via Chartmill
Globus Medical Schedules First Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire

Performance

YTD
-2.28%
-2.28%
1 Month
-0.75%
-0.75%
3 Month
+0.23%
+0.23%
6 Month
+10.56%
+10.56%
1 Year
-8.20%
-8.20%

More News

Read More
Looking for growth without the hefty price tag? Consider NYSE:GMED.
Via Chartmill
From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires
Via InvestorPlace
Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation.
Via Chartmill
The Latest Analyst Ratings For Globus Medical
Via Benzinga
NYSE:GMED is not too expensive for the growth it is showing.
Via Chartmill
Key Takeaways From Globus Medical Analyst Ratings
Via Benzinga
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
Via InvestorPlace
Exploring GLOBUS MEDICAL INC - A's Technical Signals and Breakout Potential.
Via Chartmill
Globus Medical (GMED) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Globus Medical: Q4 Earnings Insights
Via Benzinga
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
From Globus Medical
Via GlobeNewswire
Why NYSE:GMED Is a Standout High-Growth Stock in a Consolidation Phase.
Via Chartmill
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts
Via Benzinga
NYSE:GMED qualifies as a high growth stock and is consolidating.
Via Chartmill
Earnings Scheduled For February 20, 2024
Via Benzinga
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
Via Chartmill
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
From Globus Medical
Via GlobeNewswire
Do Investors Have Too Much Money Out of the Market?
Via The Motley Fool
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
Via Chartmill
NYSE:GMED stands out as a growth opportunity that won't break the bank.
Via Chartmill
7 Healthcare Stocks Taking Medicine to the Next Level
Via InvestorPlace
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
From Globus Medical
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.